Logo image of MDJH

MDJM LTD (MDJH) Stock Fundamental Analysis

NASDAQ:MDJH - Nasdaq - KYG592901097 - Common Stock - Currency: USD

0.1608  +0 (+1.07%)

After market: 0.16 0 (-0.5%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to MDJH. MDJH was compared to 64 industry peers in the Real Estate Management & Development industry. While MDJH has a great health rating, there are worries on its profitability. MDJH does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year MDJH has reported negative net income.
In the past year MDJH has reported a negative cash flow from operations.
In multiple years MDJH reported negative net income over the last 5 years.
In the past 5 years MDJH always reported negative operating cash flow.
MDJH Yearly Net Income VS EBIT VS OCF VS FCFMDJH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 1M -1M -2M

1.2 Ratios

MDJH has a Return On Assets of -39.16%. This is amonst the worse of the industry: MDJH underperforms 84.38% of its industry peers.
MDJH has a worse Return On Equity (-41.88%) than 64.06% of its industry peers.
Industry RankSector Rank
ROA -39.16%
ROE -41.88%
ROIC N/A
ROA(3y)-31.34%
ROA(5y)-17.37%
ROE(3y)-35.29%
ROE(5y)-19.58%
ROIC(3y)N/A
ROIC(5y)N/A
MDJH Yearly ROA, ROE, ROICMDJH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for MDJH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MDJH Yearly Profit, Operating, Gross MarginsMDJH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600 -800

More info and screens

8

2. Health

2.1 Basic Checks

MDJH does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MDJH has about the same amount of shares outstanding.
Compared to 5 years ago, MDJH has more shares outstanding
There is no outstanding debt for MDJH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MDJH Yearly Shares OutstandingMDJH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
MDJH Yearly Total Debt VS Total AssetsMDJH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

MDJH has an Altman-Z score of 2.43. This is not the best score and indicates that MDJH is in the grey zone with still only limited risk for bankruptcy at the moment.
MDJH's Altman-Z score of 2.43 is fine compared to the rest of the industry. MDJH outperforms 67.19% of its industry peers.
There is no outstanding debt for MDJH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.43
ROIC/WACCN/A
WACC8.48%
MDJH Yearly LT Debt VS Equity VS FCFMDJH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 2M 4M 6M 8M

2.3 Liquidity

A Current Ratio of 3.70 indicates that MDJH has no problem at all paying its short term obligations.
MDJH's Current ratio of 3.70 is amongst the best of the industry. MDJH outperforms 81.25% of its industry peers.
A Quick Ratio of 3.70 indicates that MDJH has no problem at all paying its short term obligations.
MDJH has a Quick ratio of 3.70. This is amongst the best in the industry. MDJH outperforms 85.94% of its industry peers.
Industry RankSector Rank
Current Ratio 3.7
Quick Ratio 3.7
MDJH Yearly Current Assets VS Current LiabilitesMDJH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 43.36% over the past year.
Looking at the last year, MDJH shows a very negative growth in Revenue. The Revenue has decreased by -76.59% in the last year.
The Revenue for MDJH have been decreasing by -43.01% on average. This is quite bad
EPS 1Y (TTM)43.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-64.17%
Revenue 1Y (TTM)-76.59%
Revenue growth 3Y-70.89%
Revenue growth 5Y-43.01%
Sales Q2Q%-75.11%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MDJH Yearly Revenue VS EstimatesMDJH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MDJH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MDJH Price Earnings VS Forward Price EarningsMDJH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MDJH Per share dataMDJH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MDJH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MDJM LTD

NASDAQ:MDJH (12/2/2024, 8:00:00 PM)

After market: 0.16 0 (-0.5%)

0.1608

+0 (+1.07%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.27%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.32M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 20.16
P/FCF N/A
P/OCF N/A
P/B 0.57
P/tB 0.57
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0.01
BVpS0.28
TBVpS0.28
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -39.16%
ROE -41.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-31.34%
ROA(5y)-17.37%
ROE(3y)-35.29%
ROE(5y)-19.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 99.55%
Cap/Sales 65.14%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.7
Quick Ratio 3.7
Altman-Z 2.43
F-Score3
WACC8.48%
ROIC/WACCN/A
Cap/Depr(3y)104.91%
Cap/Depr(5y)142.95%
Cap/Sales(3y)28.29%
Cap/Sales(5y)17.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-64.17%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-76.59%
Revenue growth 3Y-70.89%
Revenue growth 5Y-43.01%
Sales Q2Q%-75.11%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y38.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-19.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.45%
OCF growth 3YN/A
OCF growth 5YN/A